North America remains a dominant regional market for healthcare nanotechnology, supported by rising healthcare expenditure, rapid technological advancements, and growing awareness of personalized medicine solutions. Countries across the region are actively investing in nanotechnology research to improve disease diagnosis, treatment effectiveness, and patient outcomes. The increasing prevalence...